Savira pharmaceuticals – operating in Vienna, Austria – is focusing on the development of drugs for the treatment of influenza. Based on know-how and intellectual property from its co-founders, the European Molecular Biology Laboratory (EMBL) and the Vienna-based biotech company onepharm Research and Development GmbH, Savira manages a focused portfolio of medicinal chemistry programs aiming at the identification of lead candidates and the development of efficacious and selective anti-influenza drugs. Take a closer look on their portfolio here.